open access
Quantitative assessment of metamorphopsia using M-charts and Amsler tests in patients with non-treated central serous chorioretinopathy
open access
Abstract
INTRODUCTION. The aim of this study is the assessment of the clinical parameters related to metamorphopsia using M-charts and traditional Amsler tests in patients with central serous chorioretinopathy (CSCR).
MATERIA LS AND METHODS. Seventeen eyes of 17 patients were examined with M-charts and Amsler tests, as well as with ocular coherence tomography (OCT) at each of three visits during four months of follow-up. The rate of metamorphopsia detection was 82% with M-charts and 76% with Amsler test.
RESULTS . The vertical metamorphopsia score decreased after four months in nine patients (52.9%), 0.1° on average; increased in two patients (11.8%), mean 0.2°; and there was no change in six patients (35.3%). The horizontal metamorphopsia score decreased in seven patients (41.2%), 0.2° on average, increased in three patients (17.6%), 0.23° on average, and there was no change in seven patients (41.2%).
CONCLUSIONS. M-charts are superior to the traditional Amsler charts in the monitoring of metamorphopsia in patients with CSCR. M-charts are a good diagnostic tool for quantitative assessment of metamorphopsia and monitoring over time in patients with CSCR.
Abstract
INTRODUCTION. The aim of this study is the assessment of the clinical parameters related to metamorphopsia using M-charts and traditional Amsler tests in patients with central serous chorioretinopathy (CSCR).
MATERIA LS AND METHODS. Seventeen eyes of 17 patients were examined with M-charts and Amsler tests, as well as with ocular coherence tomography (OCT) at each of three visits during four months of follow-up. The rate of metamorphopsia detection was 82% with M-charts and 76% with Amsler test.
RESULTS . The vertical metamorphopsia score decreased after four months in nine patients (52.9%), 0.1° on average; increased in two patients (11.8%), mean 0.2°; and there was no change in six patients (35.3%). The horizontal metamorphopsia score decreased in seven patients (41.2%), 0.2° on average, increased in three patients (17.6%), 0.23° on average, and there was no change in seven patients (41.2%).
CONCLUSIONS. M-charts are superior to the traditional Amsler charts in the monitoring of metamorphopsia in patients with CSCR. M-charts are a good diagnostic tool for quantitative assessment of metamorphopsia and monitoring over time in patients with CSCR.
Keywords
metamorphopsia, M-charts, central serous chorioretinopathy
Title
Quantitative assessment of metamorphopsia using M-charts and Amsler tests in patients with non-treated central serous chorioretinopathy
Journal
Issue
Article type
Original paper
Pages
89-92
Published online
2016-11-04
Page views
644
Article views/downloads
1297
DOI
Bibliographic record
Ophthalmol J 2016;1(3):89-92.
Keywords
metamorphopsia
M-charts
central serous chorioretinopathy
Authors
Edyta Koman
Dorota Borowicz
Małgorzata Ozimek
Agnieszka Oleszczuk
Katarzyna Nowomiejska
Robert Rejdak